Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aricept in Hispanic patients with mild to moderate Alzheimer's Disease
NCT00230568Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd. Primary endpoints: Fuld Object Memory Evaluation at 12 weeks, Symbol Digit Modalities Test at 12 weeks and 2 more. Started Dec 2005; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00230568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230568.